Related by context. Frequent words. (Click for all words.) 68 Bayhill Therapeutics 66 FluoroPharma 64 Merrimack Pharmaceuticals 64 EnVivo Pharmaceuticals 64 Sofinnova Ventures 63 Pappas Ventures 63 5AM Ventures 63 Vaccinex 63 Aerovance 63 Clarus Ventures 62 PsychoGenics 62 Alnylam maintains 62 ImmuneRegen BioSciences Inc. 62 Pervasis 62 HealthCare Ventures 61 Idera Pharmaceuticals 61 Diatos 60 Sanderling Ventures 60 Inotek 60 Taligen 60 Molecular Biometrics 60 QuatRx 60 VioQuest Pharmaceuticals 60 Chemokine Therapeutics 60 AVEO Pharmaceuticals 60 TargeGen 60 Dynogen 60 Peptimmune 60 Emisphere Technologies 59 Gemin X 59 Ceregene 59 Prospect Venture Partners 59 ViaCyte 59 Elixir Pharmaceuticals 59 Genstar Capital 59 Regado Biosciences 59 Bridgescale Partners 59 Adnexus Therapeutics 59 Alseres Pharmaceuticals Inc. 59 Regulus Therapeutics 58 Sunesis Pharmaceuticals 58 Tranzyme Pharma 58 Prism Venture Partners 58 MorphoSys AG FSE MOR 58 NovaBay Pharmaceuticals 58 VIA Pharmaceuticals 58 Repligen Corporation 58 PTV Sciences 58 Aisling Capital 58 CardioTech International 58 FzioMed 58 Predictive Biosciences 58 Pequot Ventures 58 Galil Medical 58 Pharmion Corporation 58 BLSI 58 OncoMed Pharmaceuticals 58 Advanced Equities 58 Tallwood Venture Capital 58 ACLARA 58 Promedior 58 MacuSight 58 T2 Biosystems 58 AirWalk Communications 58 Gabriel Venture Partners 58 Genaera Corporation 58 ESBATech 58 Initiates Phase II 58 AGF Private Equity 57 GammaCan 57 Accuray Incorporated 57 ROTH Capital 57 OrbiMed Advisors 57 ImmunoGen Inc. 57 Archemix Corp. 57 Exploit collaboration 57 ChondroGene 57 Hybridon 57 Pharsight Corporation 57 Abingworth 57 Anthera Pharmaceuticals 57 Blueprint Ventures 57 Bruker Optics 57 KANA Software 57 Immunicon Corporation 57 Transave 57 Advanced Magnetics 57 Zafgen 57 ImmunoCellular Therapeutics 57 Cell Biosciences 57 Novartis Venture 57 ARCH Venture Partners 57 Alloy Ventures 57 Semafore 57 bluebird bio 57 Arboretum Ventures 56 Mersana 56 Metalmark Capital 56 Vicor Technologies 56 Kodiak Venture Partners 56 MedImmune Ventures